Streetbeat News

Analyst Ratings

DEN

Johnson Rice analyst Charles Meade has downgraded Denbury (NYSE:DEN) from Accumulate to Hold.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 3:52 pm

OXY

Susquehanna analyst Biju Perincheril maintains a positive outlook on Occidental Petroleum (NYSE:OXY), but has lowered the price target from $75 to $72.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 3:50 pm

MRO

Susquehanna analyst Biju Perincheril maintains a positive outlook on Marathon Oil (NYSE:MRO), but has lowered the price target from $32 to $30.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 3:50 pm

DHR

A large investor has taken a bullish stance on Danaher (NYSE:DHR), with 10 uncommon options trades spotted. The sentiment of these trades is split 50% bullish and 50% bearish. The trades include 2 puts amounting to $90,125 and 8 calls amounting to $678,596. The targeted price range for Danaher over the last 3 months is from $195.0 to $260.0. The current price of DHR is up 3.86% at $253.81. Raymond James has downgraded its action to Outperform with a price target of $270.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 3:48 pm

HES

Susquehanna analyst Biju Perincheril maintains a positive outlook on Hess (NYSE:HES), but has lowered the price target from $185 to $183.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 3:48 pm

QCOM

A whale investor has taken a bullish stance on Qualcomm (NASDAQ:QCOM), with 57% of investors opening trades with bullish expectations and 42% with bearish. The whale has been targeting a price range from $60.0 to $160.0 for Qualcomm over the last 3 months. The price of QCOM is up 2.4% at $123.62. Wolfe Research and Mizuho have downgraded their actions to Outperform and Buy with price targets of $145 and $140 respectively.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 3:48 pm

AA

Citigroup analyst Alexander Hacking has maintained a 'Buy' rating on Alcoa (NYSE:AA) but lowered the price target from $50 to $42.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:44 pm

APLS

Citigroup analyst Yigal Nochomovitz has maintained a 'Buy' rating on Apellis Pharmaceuticals (NASDAQ:APLS) but lowered the price target from $106 to $80.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:41 pm

C

CFG

Citigroup analyst Keith Horowitz maintains a Neutral rating on Citizens Financial Group (NYSE:CFG) and raises the price target from $31 to $33.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:39 pm

CRI

Citigroup analyst Paul Lejuez has maintained a 'Sell' rating on Carter's (NYSE:CRI) but raised the price target from $60 to $63.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:37 pm